Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This research is being done because people with schizophrenia often have problems with
thinking including learning, remembering, paying attention, and problem solving. During this
study, we will test if cognitive remediation (computer games made to improve thinking), used
along with a drug called atomoxetine, may help the problems in thinking as well as some of
the symptoms of schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborators:
National Institute of Mental Health (NIMH) Stanley Medical Research Institute